sj-docx-1-dst-10.1177_19322968231200901 – Supplemental material for Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use

Supplemental material, sj-docx-1-dst-10.1177_19322968231200901 for Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use by Halis K. Akturk, Casey Sakamoto, Tim Vigers, Viral N. Shah and Laura Pyle in Journal of Diabetes Science and Technology</p

Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes Management

<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-017-0272-5"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p> <p> </p> <p> </p

The Insulin-Only Bionic Pancreas Improves Glycemic Control in Non-Hispanic White and Minority Adults and Children with Type 1 Diabetes

   Objective: We evaluated the performance of the iLet® bionic pancreas (BP) in non-Hispanic Whites (‘Whites’) and in Blacks, Hispanics, and others (‘Minorities’). Research Design and Methods: A multicenter, randomized controlled trial evaluated glycemic management with the BP versus standard-of-care (SC) in 161 adult and 165 pediatric participants with type 1 diabetes over 13 weeks.  Results: In Whites (N=240), the mean baseline-adjusted difference in 13-week HbA1c between the BP and SC groups was -0.45% (95% CI -0.61% to -0.29% [-4.9, -6.6 to -3.1 mmol/mol]; P Conclusions: The BP improves glycemic control in both Whites and Minorities and offers promise in decreasing health care disparities. </p

sj-docx-1-dst-10.1177_19322968241232709 – Supplemental material for Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial

Supplemental material, sj-docx-1-dst-10.1177_19322968241232709 for Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial by Viral N. Shah, Amer Al-Karadsheh, Cathy Barnes, Jose Mandry, Samer Nakhle, Karin Wernicke-Panten, Daniel Kramer, Wolfgang Schmider, Suzanne Pierre, Lenore Teichert, Baerbel Rotthaeuser, Bhaswati Mukherjee and Timothy S. Bailey in Journal of Diabetes Science and Technology</p

sj-docx-2-dst-10.1177_19322968241234072 – Supplemental material for Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial

Supplemental material, sj-docx-2-dst-10.1177_19322968241234072 for Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial by Anders L. Carlson, Timothy E. Graham, Halis K. Akturk, David R. Liljenquist, Richard M. Bergenstal, Becky Sulik, Viral N. Shah, Mark Sulik, Peter Zhao, Peter Briggs, Ravid Sassan-Katchalski and Jordan E. Pinsker in Journal of Diabetes Science and Technology</p

sj-docx-1-dst-10.1177_19322968241234072 – Supplemental material for Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial

Supplemental material, sj-docx-1-dst-10.1177_19322968241234072 for Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial by Anders L. Carlson, Timothy E. Graham, Halis K. Akturk, David R. Liljenquist, Richard M. Bergenstal, Becky Sulik, Viral N. Shah, Mark Sulik, Peter Zhao, Peter Briggs, Ravid Sassan-Katchalski and Jordan E. Pinsker in Journal of Diabetes Science and Technology</p

sj-docx-3-dst-10.1177_19322968241229074 – Supplemental material for Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology

Supplemental material, sj-docx-3-dst-10.1177_19322968241229074 for Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology by Viral N. Shah, Halis K. Akturk, Alex Trahan, Nicole Piquette, Alex Wheatcroft, Elain Schertz, Karen Carmello, Lars Mueller, Kirstin White, Larry Fu, Ravid Sassan-Katchalski, Laurel H. Messer, Steph Habif, Alex Constantin and Jordan E. Pinsker in Journal of Diabetes Science and Technology</p

sj-docx-1-dst-10.1177_19322968241229074 – Supplemental material for Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology

Supplemental material, sj-docx-1-dst-10.1177_19322968241229074 for Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology by Viral N. Shah, Halis K. Akturk, Alex Trahan, Nicole Piquette, Alex Wheatcroft, Elain Schertz, Karen Carmello, Lars Mueller, Kirstin White, Larry Fu, Ravid Sassan-Katchalski, Laurel H. Messer, Steph Habif, Alex Constantin and Jordan E. Pinsker in Journal of Diabetes Science and Technology</p

sj-docx-2-dst-10.1177_19322968241229074 – Supplemental material for Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology

Supplemental material, sj-docx-2-dst-10.1177_19322968241229074 for Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology by Viral N. Shah, Halis K. Akturk, Alex Trahan, Nicole Piquette, Alex Wheatcroft, Elain Schertz, Karen Carmello, Lars Mueller, Kirstin White, Larry Fu, Ravid Sassan-Katchalski, Laurel H. Messer, Steph Habif, Alex Constantin and Jordan E. Pinsker in Journal of Diabetes Science and Technology</p